| Stage | DBD | % of rev | NATL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $994M | 100.00% | $1.1B | 100.00% | NATL ×1.11 |
| Gross profit | $247M | 24.86% | $309M | 28.01% | NATL +3.2pp |
| Operating income | $39M | 3.90% | $156M | 14.14% | NATL +10.2pp |
| Pre-tax income | $15M | 1.54% | $90M | 8.16% | NATL +6.6pp |
| Net income | $7M | 0.71% | $65M | 5.89% | NATL +5.2pp |
| Stage | DBD | NATL | Gap · A − B |
|---|---|---|---|
| Revenue | $994M100.00% | $1.1B100.00% | NATL ×1.11 |
| Gross profit | 24.86%$247M | 28.01%$309M | NATL +3.2pp |
| Operating income | 3.90%$39M | 14.14%$156M | NATL +10.2pp |
| Pre-tax income | 1.54%$15M | 8.16%$90M | NATL +6.6pp |
| Net income |
| 0.71%$7M |
| 5.89%$65M |
| NATL +5.2pp |